Coaxial 2.2-mm microphacoemulsification reduces surgically induced astigmatism
September 13th 2005Lisbon, Portugal - Coaxial microphacoemulsification performed through a 2.2-mm incision results in significantly less induced astigmatism than conventional coaxial phacoemulsification through a 3-mm incision, said Samuel Masket, MD, clinical professor of ophthalmology, Jules Stein Eye Institute, University of California-Los Angeles, United States.
Wavefront-guided enhancement of highly aberrated eyes safe, predictable in study
September 13th 2005Lisbon, Portugal - Preliminary data have demonstrated that VISX CustomVue wavefront-guided enhancement of eyes with high aberrations after a previous refractive surgery is safe and effective. Edward Manche, MD, described the retrospective analysis of 120 eyes of 102 patients Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
EpiLASIK efficacious 1 year after treatment with low patient discomfort, study finds
September 13th 2005Lisbon, Portugal - EpiLASIK is a safe and effective alternative refractive procedure to treat patients with myopia. The 1-year data indicate that the patients have good refractive results and stable vision. Vikentia Katsanevaki, MD, PhD, described the study Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
Coaxial 2.2-mm microphacoemulsification reduces surgically induced astigmatism
September 13th 2005Lisbon, Portugal - Coaxial microphacoemulsification performed through a 2.2-mm incision results in significantly less induced astigmatism than conventional coaxial phacoemulsification through a 3-mm incision, said Samuel Masket, MD, clinical professor of ophthalmology, Jules Stein Eye Institute, University of California-Los Angeles, United States.
Customized LASIK provides measurable clinical and economic benefits
September 13th 2005Lisbon, Portugal - A shift from conventional to wavefront-guided LASIK has resulted in reduced enhancement rates that translate into significant cost savings to the practice, said Richard L. Lindstrom, MD, adjunct professor emeritus, department of ophthalmology, University of Minnesota, and founding partner, Minnesota Eye Consultants, Minneapolis, United States.
Beta-blocker effective to manage regression after refractive surgery
September 13th 2005Lisbon, Portugal - Treatment with a topical beta-blocker is effective for preventing regression after LASIK to treat myopia. However, there is no way to predict which patients will respond to the therapy, according to Takayoshi Suzuki, MD, who reported his findings Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
Mitomycin C aids corneal healing after photoablation
September 13th 2005Lisbon, Portugal - Application of mitomycin C after PRK prevents the development of corneal haze and improves visual acuity. Ewa Mrukwa-Kominek, MD, reported these findings Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
Goblet cell dysfunction may occur after LASIK
September 13th 2005Lisbon, Portugal - Dry eye syndrome after LASIK may be the result of goblet cell dysfunction. Extended application of artificial tears may be warranted to facilitate the return to normal function, Ahmed Galal, MD, PhD, said Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
Nidek receives CE Mark for excimer laser system
September 12th 2005Lisbon, Portugal - Nidek Co., Gamagori, Japan, has received a CE Mark for its new and advanced refractive surgery laser system, the EC-5000CXIII. This regulatory milestone clears the way for NIDEK to commercialize and market the new laser platform for refractive surgery, throughout the world, especially in Europe and the Middle East, the company said.
Artiflex and I-Care phakic IOLs are accurate; some complications exist with both, study finds
September 12th 2005Lisbon, Portugal - Both the Artiflex (Ophtec) iris-claw IOL and the I-Care (Cornéal) phakic angle-supported IOL are effective and provide good refractive outcomes, Antonio Marinho, MD, reported Monday at the European Society of Cataract and Refractive Surgeons meeting.
Duet-Kelman phakic IOL seems safe and efficacious 1 year after implantation
September 12th 2005Lisbon, Portugal - The Duet-Kelman phakic lens seems to be safe and efficacious to correct moderate and high degrees of myopia, and patients with high degrees of myopia expressed satisfaction with their increased vision, according to Gonzalo Bernabeu, MD. He reported his experience with the IOL Monday at the European Society of Cataract and Refractive Surgeons meeting.
Risk factors associated with endophthalmitis after cataract surgery
September 12th 2005Lisbon, Portugal - Data on the development of endophthalmitis have been reported continuously since 1994 in Sweden, and the rate of endophthalmitis has been decreasing similar to international rates. Per Montan, MD, reported the results of a multicenter study on the risk factors that have been identified for the development of endophthalmitis Monday at the European Society of Cataract and Refractive Surgeons meeting.
ASCRS/ESCRS survey: Dislocation, decentration top reasons for foldable IOL explantation
September 12th 2005Lisbon, Portugal - The results of the 7th annual survey on foldable IOLs indicate that dislocation and decentration are by far the most common reasons for lens explantation, with incorrect lens power the next most important factor. Nick Mamalis, MD, reported the results of the survey - conducted by the American Society of Cataract and Refractive Surgery (ASCRS) and the European Society of Cataract and Refractive Surgeons (ESCRS) - Monday morning at ESCRS’ annual meeting.
Coaxial microphaco a major step forward in cataract surgery evolution
September 12th 2005Lisbon, Portugal - Coaxial microphacoemulsification performed through a 2.2-mm incision is a new technique that can be readily learned by cataract surgeons skilled in phacoemulsification. The technique affords patients the combined benefits of ultra-small incision surgery and conventional foldable IOLs, Robert H. Osher, MD, said Monday at the European Society of Cataract and Refractive Surgeons meeting.
New instrumentation offers advance for IOP measurement
September 11th 2005Lisbon, Portugal - Newer tonometry technology seems to offer an improvement on Goldmann tonometry, which has been the gold standard for measuring IOP during the last 50 years, said Jay Pepose, MD, PhD, professor of clinical ophthalmology and visual sciences, Washington University, School of Medicine, St. Louis, MO, United States.
New instrumentation offers advance for IOP measurement
September 11th 2005Lisbon, Portugal - Newer tonometry technology seems to offer an improvement on Goldmann tonometry, which has been the gold standard for measuring IOP during the last 50 years, said Jay Pepose, MD, PhD, professor of clinical ophthalmology and visual sciences, Washington University, School of Medicine, St. Louis, MO, United States.
What’s on the horizon for presbyopia: the refractive surgeon’s final frontier?
September 11th 2005Lisbon, Portugal - If presbyopia is the “final frontier” in refractive surgery, which surgical approach will stand out as the winner in treating patients with the condition? Will it be corneal surgery, intraocular surgery, or phakic-versus-pseudophakic approaches?
Tissue adhesive effective in total anterior lamellar keratoplasty
September 11th 2005Lisbon, Portugal - The use of fibrin glue seems to be effective and safe in total anterior lamellar keratoplasty (TALK), a procedure that completely exposes Descemet’s membrane within the area of host corneal trephination combined with transplantation of donor cornea without Descemet’s membrane and endothelium. Thomas John, MD, explained the procedure Sunday at the European Society of Cataract and Refractive Surgeons meeting.
Staged flap creation, ablation preferred for LASIK correction of high astigmatism post-PK
September 11th 2005Lisbon, Portugal - LASIK is an effective tool in the management of high astigmatism after penetrating keratoplasty (PK). Furthermore, a two-step technique may be preferred over a one-stage procedure because it allows for better evaluation of refractive changes induced by the keratectomy, said Ahmed Galal, MD, PhD.
ESCRS to handle administration of EURETINA
September 10th 2005Lisbon, Portugal – In an effort to create a synergy that will benefit all of the European ophthalmic community, the European Society of Cataract and Refractive Surgeons (ESCRS) and the European Society of Retina Specialists (EURETINA) have announced that the ESCRS will assume the administrative duties of the retina society.
Study finds no signs of toxicity with viscoanesthesia OVD
September 10th 2005Lisbon, Portugal – A viscoanesthesia-type of an ophthalmic viscosurgical device (OVD) did not show toxic or cataractogenic effects in rabbit eyes, according to a four-part study conducted at the Moran Eye Institute at the University of Utah, Salt Lake City, United States.
Blue-blocking IOLs may not be the panacea expected
September 10th 2005Lisbon, Portugal – Blue-blocking IOLs, which recently have been promoted as being vision protecting, may not be so. Martin Mainster, PhD, MD, of the University of Kansas Medical School, Kansas City, explained that the argument in favor of blue-blocking IOLs is theoretical at the European Society of Cataract and Refractive Surgeons.
ESCRS and ASCRS celebrate 10 years of co-editing cataract/refractive journal
September 10th 2005Lisbon, Portugal – The European Society of Cataract and Refractive Surgeons (ESCRS) and the American Society of Cataract and Refractive Surgery (ASCRS) celebrated 10 years of co-editing the Journal of Cataract and Refractive Surgery at the ESCRS Congress President’s Dinner on Friday night.